BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 33938575)

  • 1. Long-term trajectory of acquired demyelinating syndrome and multiple sclerosis in children.
    Eusebi A; Zara P; Zarbo IR; Festa S; Dessì V; Pes V; Salis F; Sotgiu G; Carta A; Sotgiu S
    Dev Med Child Neurol; 2021 Sep; 63(9):1059-1065. PubMed ID: 33938575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of paediatric multiple sclerosis and other acquired demyelinating syndromes: 10-year follow-up surveillance study.
    Abdel-Mannan O; Absoud M; Benetou C; Hickson H; Hemingway C; Lim M; Wright S; Hacohen Y; Wassmer E;
    Dev Med Child Neurol; 2022 Apr; 64(4):502-508. PubMed ID: 34693523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and outcome of acquired demyelinating syndromes in Dutch children: update of a nationwide and prospective study.
    de Mol CL; Wong YYM; van Pelt ED; Ketelslegers IA; Bakker DP; Boon M; Braun KPJ; van Dijk KGJ; Eikelenboom MJ; Engelen M; Geleijns K; Haaxma CA; Niermeijer JMF; Niks EH; Peeters EAJ; Peeters-Scholte CMPCD; Poll-The BT; Portier RP; de Rijk-van Andel JF; Samijn JPA; Schippers HM; Snoeck IN; Stroink H; Vermeulen RJ; Verrips A; Visscher F; Vles JSH; Willemsen MAAP; Catsman-Berrevoets CE; Hintzen RQ; Neuteboom RF
    J Neurol; 2018 Jun; 265(6):1310-1319. PubMed ID: 29569176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
    van Pelt ED; Mescheriakova JY; Makhani N; Ketelslegers IA; Neuteboom RF; Kundu S; Broer L; Janssens C; Catsman-Berrevoets CE; van Duijn CM; Banwell B; Bar-Or A; Hintzen RQ
    Neurology; 2013 Dec; 81(23):1996-2001. PubMed ID: 24198294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Value of Oligoclonal Bands in Children: A Nationwide Population-Based Cohort Study.
    Boesen MS; Born AP; Jensen PEH; Sellebjerg F; Blinkenberg M; Lydolph MC; Jørgensen MK; Rosenberg L; Thomassen JQ; Børresen ML
    Pediatr Neurol; 2019 Aug; 97():56-63. PubMed ID: 31060768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide Incidence of Acquired Central Nervous System Demyelination in Icelandic Children.
    Gudbjornsson BT; Haraldsson Á; Einarsdóttir H; Thorarensen Ó
    Pediatr Neurol; 2015 Dec; 53(6):503-7. PubMed ID: 26463471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders.
    Longoni G; Brown RA; MomayyezSiahkal P; Elliott C; Narayanan S; Bar-Or A; Marrie RA; Yeh EA; Filippi M; Banwell B; Arnold DL;
    Brain; 2017 May; 140(5):1300-1315. PubMed ID: 28334875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination.
    Disanto G; Magalhaes S; Handel AE; Morrison KM; Sadovnick AD; Ebers GC; Banwell B; Bar-Or A;
    Neurology; 2011 Mar; 76(9):781-6. PubMed ID: 21288988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of acquired demyelination of the CNS in Canadian children.
    Banwell B; Kennedy J; Sadovnick D; Arnold DL; Magalhaes S; Wambera K; Connolly MB; Yager J; Mah JK; Shah N; Sebire G; Meaney B; Dilenge ME; Lortie A; Whiting S; Doja A; Levin S; MacDonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Guimond C; Cooper P; Grand'Maison F; Baird JB; Bhan V; Bar-Or A
    Neurology; 2009 Jan; 72(3):232-9. PubMed ID: 19153370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and Behavioral Functioning in Childhood Acquired Demyelinating Syndromes.
    Till C; Noguera A; Verhey LH; O'Mahony J; Yeh EA; Mah JK; Sinopoli KJ; Brooks BL; Aubert-Broche B; Collins DL; Narayanan S; Arnold DL; Banwell BL
    J Int Neuropsychol Soc; 2016 Nov; 22(10):1050-1060. PubMed ID: 27903328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Demyelinating Syndromes: A report of child neurology department of Sfax University Hospital.
    Zouari Mallouli S; Ben Nsir S; Bouchaala W; Kamoun Feki F; Charfi Triki C
    Mult Scler Relat Disord; 2021 Nov; 56():103291. PubMed ID: 34624647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children.
    Langer-Gould A; Zhang JL; Chung J; Yeung Y; Waubant E; Yao J
    Neurology; 2011 Sep; 77(12):1143-8. PubMed ID: 21865580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric acquired demyelinating syndrome (ADS) in inpatient hospital settings: The hospitalization rate, costs, and outcomes in the US.
    Minegishi M; Takahashi T; Testa M
    Mult Scler Relat Disord; 2019 Sep; 34():150-157. PubMed ID: 31295724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric-onset multiple sclerosis and other acquired demyelinating syndromes of the central nervous system in Denmark during 1977-2015: A nationwide population-based incidence study.
    Boesen MS; Magyari M; Koch-Henriksen N; Thygesen LC; Born AP; Uldall PV; Blinkenberg M
    Mult Scler; 2018 Jul; 24(8):1077-1086. PubMed ID: 28608742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric clinically isolated syndromes: report of seven cases, differential diagnosis and literature review.
    Trabatti C; Foiadelli T; Spartà MV; Gagliardone C; Rinaldi B; Delmonte M; Lozza A; Savasta S
    Childs Nerv Syst; 2016 Jan; 32(1):69-77. PubMed ID: 26584554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes.
    Duignan S; Wright S; Rossor T; Cazabon J; Gilmour K; Ciccarelli O; Wassmer E; Lim M; Hemingway C; Hacohen Y
    Dev Med Child Neurol; 2018 Sep; 60(9):958-962. PubMed ID: 29468668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell activation marker sCD27 is associated with clinically definite multiple sclerosis in childhood-acquired demyelinating syndromes.
    Wong YYM; van der Vuurst de Vries RM; van Pelt ED; Ketelslegers IA; Melief MJ; Wierenga AF; Catsman-Berrevoets CE; Neuteboom RF; Hintzen RQ
    Mult Scler; 2018 Nov; 24(13):1715-1724. PubMed ID: 30019626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
    Banwell B; Bar-Or A; Arnold DL; Sadovnick D; Narayanan S; McGowan M; O'Mahony J; Magalhaes S; Hanwell H; Vieth R; Tellier R; Vincent T; Disanto G; Ebers G; Wambera K; Connolly MB; Yager J; Mah JK; Booth F; Sebire G; Callen D; Meaney B; Dilenge ME; Lortie A; Pohl D; Doja A; Venketaswaran S; Levin S; Macdonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Cooper P; Grand'maison F; Baird JB; Bhan V; Marrie RA
    Lancet Neurol; 2011 May; 10(5):436-45. PubMed ID: 21459044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigue, depression, and quality of life in children with multiple sclerosis: a comparative study with other demyelinating diseases.
    Florea A; Maurey H; Le Sauter M; Bellesme C; Sevin C; Deiva K
    Dev Med Child Neurol; 2020 Feb; 62(2):241-244. PubMed ID: 30977123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.